Serum sFas and Anemia in Acute Renal Failure
Author Information
Author(s): Góes MA, Dalboni MA, Quinto BMR, Iizuka IJ, Monte JC, dos Santos OF Pavão, Pereira VG, de Souza Durão M Jr, Batista MC, Cendoroglo M
Primary Institution: Federal University of São Paulo - UNIFESP
Hypothesis
Serum levels of sFas are associated with anemia and increased need for serum Epo levels in acute renal failure and critical illness.
Conclusion
sFas is associated with anemia in acute renal failure and critically ill patients.
Supporting Evidence
- The CVVHDF and non-ARF groups had higher serum levels of Epo, IL-6, IL-10 and ferritin than the other groups.
- Hgb levels were lower in the CVVHDF group than in the other groups.
- Serum sFas levels were higher in uremic patients (CVVHDF and ESRD groups).
- Hgb levels correlated negatively with serum levels of IL-6, sFas, TNFα, iron, ferritin, and transferrin saturation.
- Levels of IL-6, sFas, and TNFα correlated negatively with Hgb in critically ill patients after adjusting for markers of iron store and inflammation.
Takeaway
This study found that a substance called sFas is linked to low blood levels in patients with kidney failure and those who are very sick.
Methodology
The study involved 72 critically ill patients with acute renal failure, 29 chronic hemodialysis patients, and 29 healthy volunteers, examining the relationships between hemoglobin and various serum levels.
Participant Demographics
72 critically ill patients with ARF, 29 chronic hemodialysis patients, and 29 healthy volunteers.
Statistical Information
P-Value
P < 0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website